Last reviewed · How we verify
Cloxyquin (cloxiquine)
Cloxyquin (generic name: cloxiquine) is a cloxiquine drug. It is currently in unknown development.
Cloxyquin works by binding to and inhibiting the enzyme methionine aminopeptidase 2, which plays a role in protein synthesis.
Cloxyquin is a small molecule. It is also known by several synonyms, including CLOXIQUINA, CLOXIQUINE, and CLOXYQUIN.
At a glance
| Generic name | cloxiquine |
|---|---|
| Drug class | cloxiquine |
| Target | Methionine aminopeptidase 1, Methionine aminopeptidase 2, Catechol O-methyltransferase |
| Therapeutic area | Oncology |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like factories that build proteins. Methionine aminopeptidase 2 is a key tool in this process, helping to add the right building blocks to the protein. Cloxyquin blocks this tool, which can help to slow down or stop the growth of certain cells, such as cancer cells.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cloxyquin CI brief — competitive landscape report
- Cloxyquin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Cloxyquin
What is Cloxyquin?
How does Cloxyquin work?
What is the generic name of Cloxyquin?
What drug class is Cloxyquin in?
What development phase is Cloxyquin in?
What does Cloxyquin target?
Related
- Drug class: All cloxiquine drugs
- Target: All drugs targeting Methionine aminopeptidase 1, Methionine aminopeptidase 2, Catechol O-methyltransferase
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Oncology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing